Effect of postoperative complications on adjuvant chemotherapy use for stage III colon cancer

Annals of Surgery

Volumn 258, Issue 6, 2013, Pages 847-853

  Merkow, Ryan P ^a,b,c   Bentrem, David J ^b,d   Mulcahy, Mary F ^b   Chung, Jeanette W ^b   Abbott, Daniel E ^e   Kmiecik, Thomas E ^b   Stewart, Andrew K ^a   Winchester, David P ^a   Ko, Clifford Y ^a,f   Bilimoria, Karl Y ^a,b  

^a AMERICAN COLLEGE OF SURGEONS   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d JESSE BROWN VA MEDICAL CENTER   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ACS NSQIP; adjuvant chemotherapy; colon cancer; complications; NCDB

Indexed keywords

ABSCESS; ADJUVANT CHEMOTHERAPY; ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTIFICIAL VENTILATION; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; COLON ADENOCARCINOMA; COLON CANCER; COLON RESECTION; COMORBIDITY; CONFERENCE PAPER; DIGESTIVE TRACT INTUBATION; FEMALE; HUMAN; KIDNEY FAILURE; LUNG INSUFFICIENCY; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REOPERATION; SEPSIS; SEPTIC SHOCK; SURGICAL INFECTION; THERAPY DELAY; TREATMENT REFUSAL; URINARY TRACT INFECTION; VENOUS THROMBOEMBOLISM;

AGED; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS;

EID: 84888131650     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000312     Document Type: Conference Paper

References (34)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10-29.
2. Siegel RL, Ward EM, Jemal A. Trends in colorectal cancer incidence rates in the United States by tumor location and stage, 1992-2008. Cancer Epidemiol Biomarkers Prev. 2012;21:411-416.
3. American Cancer Society. Cancer Prevention and Early Detection Facts & Figures 2013. Available at: http://www.cancer.org/research/ cancerfactsfigures/cancerpreventionearlydetectionfactsfigures/ cancer-prevention-early-detection-facts-figures-2013. Accessed August 30, 2013.
4. Compton CC, Fielding LP, Burgart LJ, et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000:124:979-994.
5. Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990;322:352-358.
6. Laurie JA, Moertel CG, Fleming TR, et al. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol. 1989;7:1447-1456.
7. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990;264:1444-1450.
8. American College of Surgeons. Cancer programs. CoC quality care measures. Available at: http://www.facs.org/cancer/qualitymeasures.html. Accessed August 15, 2011.
9. The National Quality Forum. Adjuvant chemotherapy is considered or administered within 4 months of surgery to patients under the age of 80 with AJCC III colon cancer (NQF 0223). Available at: http://www .qualityforum.org/ MeasureDetails.aspx?actid=0&SubmissionId=453-k= Chemotherapy. Accessed April 25, 2012.
10. Centers for Medicare & Medicaid Services. Fiscal Year 2013 Inpatient Prospective Payment System Proposed Rule. Available at: http://www .cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/ FY-2014-IPPS-Proposed-Rule-Home-Page-Items/FY-2014-IPPS-Proposed-Rule-CMS-1599- P-Regulations.html. Accessed August 30, 2013.
11. Schrag D, Cramer LD, Bach PB, et al. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst. 2001;93:850-857.
12. Jessup JM, Stewart A, Greene FL, et al. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. JAMA. 2005;294:2703-2711.
13. Ayanian JZ, Zaslavsky AM, Fuchs CS, et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol. 2003;21:1293-1300.
14. Chagpar R, Xing Y, Chiang YJ, et al. Adherence to stage-specific treatment guidelines for patients with colon cancer. J Clin Oncol. 2012;30: 972-979.
15. Lee L, Cheung WY, Atkinson E, et al. Impact of comorbidity on chemotherapy use and outcomes in solid tumors: a systematic review. J Clin Oncol. 2011;29:106-117.
16. Cohen ME, Bilimoria KY, Ko CY, et al. Development of an American College of Surgeons National Surgery Quality Improvement Program: morbidity and mortality risk calculator for colorectal surgery. J Am Coll Surg. 2009;208:1009-1016.
17. Lawson EH, Ko CY, Louie R, et al. Linkage of a clinical surgical registry with Medicare inpatient claims data using indirect identifiers. Surgery. 2013;153:423-430.
18. American College of Surgeons-National Surgical Quality Improvement Program. Available at: http://site.acsnsqip.org. Accessed August 30, 2013.
19. Khuri SF, Henderson WG, Daley J, et al. Successful implementation of the Department of Veterans Affairs' National Surgical Quality Improvement Program in the private sector: the Patient Safety in Surgery study. Ann Surg. 2008;248:329-336.
20. American College of Surgeons-National Surgical Quality Improvement Program: Semiannual Report July 2011. Chicago, IL: American College of Surgeons; 2011.
21. Shiloach M, Frencher SK Jr, Steeger JE, et al. Toward robust information: data quality and inter-rater reliability in the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg. 2010;210:6-16.
22. National Cancer Data Base. Available at: http://www.facs.org/cancer/ncdb/ index.html. Accessed August 30, 2013.
23. Bilimoria KY, Stewart AK, Winchester DP, et al. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008;15:683-690.
24. CPT 2011: Current Procedural Terminology. Chicago, IL: American Medical Association; 2011.
25. Department of Health and Human Services. The International Classification of Diseases, 9th Revised. Clinical Modification: ICD-9 CM. Washington, DC: Government Printing Office; 1998.
26. International Classification of Disease for Oncology. 3rd ed. Geneva: World Health Organization; 2000.
27. AJCC Cancer Staging Manual. 7th ed. Chicago IL: Springer; 2010.
28. Hendren S, Birkmeyer JD, Yin H, et al. Surgical complications are associated with omission of chemotherapy for stage III colorectal cancer. Dis Colon Rect. 2010;53:1587-1593.
29. Greenland S: Principles of multilevelmodelling. Int J Epidemiol. 2000;29:158-167.
30. Kahn KL, Adams JL,Weeks JC, et al. Adjuvant chemotherapy use and adverse events among older patientswith stage III colon cancer. JAMA. 2010;303:1037-1045.
31. Davenport DL, Holsapple CW, Conigliaro J: Assessing surgical quality using administrative and clinical data sets: a direct comparison of the University HealthSystem Consortium Clinical Database and the National Surgical Quality Improvement Program data set. Am J Med Qual. 2009;24:395-402.
32. Steinberg SM, Popa MR, Michalek JA, et al. Comparison of risk adjustment methodologies in surgical quality improvement. Surgery. 2008;144:662-667; discussion 662-667.
33. Committee on Quality of Health Care in America Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century.Washington, DC: National Academies Press; 2001.
34. Biagi JJ, Raphael MJ, MackillopWJ, et al. Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis. JAMA. 2011;305:2335-2342.